IRD
Opus Genetics, Inc.
4.60$
+1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.3% | 99.5% | 99.4% | 99.4% | 99.6% | 99.7% | 99.7% | |
| 78.1% | 93.6% | 91.0% | 92.4% | 90.7% | 82.3% | 86.8% | 83.9% | 85.3% | 89.7% | 89.8% | 95.5% | |
| 78.2% | 93.6% | 91.0% | 92.4% | 90.7% | 82.3% | 86.8% | 83.9% | 85.3% | 89.7% | 89.8% | 95.5% | |
| 20.9% | 4.3% | 6.0% | 5.1% | 8.2% | 15.7% | 9.9% | 11.8% | 11.8% | 6.3% | 4.1% | 1.6% | |
| 7.2% | 7.5% | 11.2% | 9.4% | 15.1% | 81.8% | 89.5% | 54.8% | 83.5% | 69.5% | 168.6% | 114.0% | |
| 7.2% | 7.5% | 11.2% | 9.4% | 15.1% | 30.6% | 50.3% | 52.2% | 80.5% | 15.5% | 14.0% | 8.2% | |
| 3.5% | 4.0% | 4.0% | 1.4% | 2.1% | 8.5% | 5.0% | 3.8% | 6.6% | 6.6% | 6.6% | 2.0% | |
| – | – | – | – | – | – | – | 2.6% | 3.0% | 2.2% | 1.8% | 38.9% | |
| 92.8% | 92.5% | 88.8% | 90.6% | 84.9% | 18.2% | 10.5% | 45.2% | 16.5% | 30.5% | -68.6% | -14.0% | |
| -141.5% | -151.0% | -170.8% | -214.9% | -257.2% | -377.1% | -305.6% | -399.9% | -476.3% | -375.4% | -380.5% | -282.1% | |
| 41.3% | 40.8% | 47.3% | 57.6% | 64.7% | 85.7% | 70.3% | 163.9% | 195.6% | 1,238.4% | 1,301.0% | 119.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.